Loading...
  • bivalent vaccine
  • There was a decline in HPV 16/18 ( p = 0.004) but not in HPV 6/11 ( p = 0.172) in the post-vaccination period among men who recently arrived in Australia from countries with a bivalent vaccine programme. (bmj.com)
  • The decline in HPV 16/18, but not in HPV 6/11 among overseas-born males predominantly from countries with a bivalent vaccine programme, suggests these men receive herd protection for 16/18 from their vaccinated female partners in their countries of origin. (bmj.com)
  • lesions
  • Radical vaginal trachelectomy with pelvic lymph node dissection is appropriate for fertility preservation in women with stage IA2 disease and those with stage IB1 disease whose lesions are 2 cm or smaller. (medscape.com)
  • The main objectives of the Costa Rica Vaccine Trial were to evaluate the efficacy of the candidate vaccine to prevent persisting HPV-16/18 infections and related histopathologically confirmed CIN2+ lesions among the according to protocol subcohort and the overall population enrolled in the study. (clinicaltrials.gov)
  • But tests to look for these changes are also being done less often in women age 21 and younger, which could account for at least some of the decline in "cervical lesions," the researchers point out. (reuters.com)
  • The decreases in high grade lesions are most likely due to a combination of decreased screening and receipt of HPV vaccine in this population of young women," said study leader Susan Hariri of the Centers for Disease Control and Prevention in Atlanta, Georgia. (reuters.com)
  • During this time, 9,119 cases of high-grade cervical cancer lesions were diagnosed among 18 to 39 year old women. (reuters.com)
  • Also, cervical cancer is rare in young women aged less than 21 years and in general, it takes years for high-grade lesions to become severe enough to be considered cancer. (reuters.com)
  • Not screening younger women helps avoid unnecessary medical and surgical treatments in those whose precancerous lesions would likely have healed on their own, she said. (reuters.com)
  • At least some of the decrease in lesions may also be due to HPV vaccination, she said. (reuters.com)
  • Australian data, which is better than North American data, indicates that the vaccine does reduce lesions, he said. (reuters.com)
  • conjugate vaccine
  • The meningococcal conjugate vaccine (MCV4) is preferred for adults ages 55 and younger. (aafp.org)
  • Revaccination with meningococcal conjugate vaccine (MCV4) is now recommended for children who remain at increased risk for meningococcal disease. (aafp.org)
  • The recommendations for vaccinating children and adolescents against pneumococcal disease have been updated based on FDA approval of a new 13-valent pneumococcal polysaccharide-protein conjugate vaccine (PCV13). (uspharmacist.com)
  • adolescent
  • The ACIP annually reviews the recommended immunization schedules to ensure that they best reflect current recommendations for the licensed vaccines.The ACIP produced the adult immunization schedule in conjunction with the American Academy of Family Physicians and the American College of Physicians, and the childhood and adolescent schedule in conjunction with the AAFP, the American Academy of Pediatrics and the American College of Obstetricians and Gynecologists. (aafp.org)
  • The 2010 childhood and adolescent schedules note the ACIP's preference for use of combination vaccines over separate injections of equivalent component vaccines. (aafp.org)
  • There are also new recommendations for the recently licensed HPV2 vaccine in adolescent females and the HPV4 vaccine in adolescent males, similar to those for adults. (aafp.org)
  • Administering the vaccines to the pre-adolescent population maximises the chances of most of the population achieving immunity before HPV exposure. (mja.com.au)
  • Favourable estimates of the cost-effectiveness of a catch-up immunisation program for women up to the age of 26 years in economic models adapted to Australian data 4 , 5 led to federal government funding of a universal immunisation program for girls aged 12 and 13 in Australia, with a 2-year catch-up program for older adolescent and young adult women. (mja.com.au)
  • Our research group started to treat adolescent females suffering from the AEs. (hindawi.com)
  • To survey the characteristics of and the effects of cognitive behavioral therapy on adolescent female suffering from the AEs in Japanese multidisciplinary pain centers. (hindawi.com)
  • In Japan, after receiving human papillomavirus vaccination, a significant number of adolescent girls experienced various symptoms, the vast majority of which have been ascribed to chronic regional pain syndrome, orthostatic intolerance, and/or cognitive dysfunction. (springer.com)
  • Receiving the human papillomavirus vaccine does not increase rates of sexually transmitted infections (STIs) in adolescent females. (oncologynurseadvisor.com)
  • adult
  • Adult vaccination coverage, however, remains low for most routinely recommended vaccines ( 1 ) and well below Healthy People 2020 targets. (cdc.gov)
  • The Community Preventive Services Task Force and other authorities have recommended that health-care providers incorporate vaccination needs assessment, recommendation, and offer of vaccination into routine clinical practice for adult patients ( 4,5 ). (cdc.gov)
  • Questions about receipt of recommended vaccinations for adults are asked of one randomly selected adult within each family in the household. (cdc.gov)
  • This trial studies whether the nonavalent human papillomavirus vaccine given to adult women prior to kidney transplantation can help the body build and maintain an effective immune response during the post-transplant period when they receive immunosuppressive drugs to prevent transplant rejection. (mayo.edu)
  • PCV13
  • PCV13 was approved to prevent IPD caused by the 13 serotypes in the vaccine and to prevent otitis media caused by seven of the serotypes (the same ones as in PCV7). (uspharmacist.com)
  • trials
  • To date most human vaccine trials utilize aluminum (Al) adjuvants as placebos despite much evidence showing that Al in vaccine-relevant exposures can be toxic to humans and animals. (springer.com)
  • 2 This vaccine was developed because of the decreased immune response to standard dosing in elderly patients in some clinical trials. (uspharmacist.com)
  • tetanus
  • In 2012, the proportion of adults receiving any tetanus toxoid-containing vaccine during the past 10 years was 64.2% for adults aged 19-49 years, 63.5% for adults aged 50-64 years, and 55.1% for adults aged ≥65 years ( Table 1 ). (cdc.gov)
  • The proportion of adults receiving tetanus vaccination during the past 10 years across all age groups did not change compared with 2011 ( 1 ). (cdc.gov)
  • Types
  • Available vaccines protect against either two, four, or nine types of HPV. (wikipedia.org)
  • Additional vaccine candidate research is occurring for next generation products to extend protection against additional HPV types. (wikipedia.org)
  • immune
  • As a more robust immune response to vaccination is achieved at this age, protection is likely to endure through the years of maximal exposure. (mja.com.au)
  • This study will help inform our scientific understanding about vaccine-induced immune responses among immunosuppressed individuals. (mayo.edu)
  • However, standard vaccination series have not been very successful because a compromised immune system may not produce the desired immune response to a vaccine. (knowcancer.com)
  • biopsy
  • Normal cervical biopsy, a normal Pap smear, and a negative human papillomavirus (HPV) test were seen in 14 of the 28 patients in the treatment group at 6-month follow-up, compared with 6 of the 17 patients in the observation group. (medscape.com)
  • Patient number and Breed Biopsy to Vaccine #1 (days) Vaccine #1 to chemo (days) Diagnosis to outcome (days) 1. (zanran.com)
  • years
  • Analyses were conducted to estimate Tdap vaccination of adults aged ≥65 years being collected in the NHIS for the first time starting in 2012. (cdc.gov)
  • 50% of young women and men are infected with HPV16 within 3 years of onset of sexual activity ( 11 ). (jimmunol.org)
  • The role of these vaccines for women older than 26 years is yet to be established. (mja.com.au)
  • In so doing, we provide information to help medical practitioners advise women over 26 years of age on the risks and benefits of HPV vaccination. (mja.com.au)
  • This study will evaluate the consistency of consecutive vaccine lots and the non-inferiority of modified manufacturing processes of GSK Biologicals HPV-16/18 vaccine and the vaccine safety, over 12 months, in young adolescents and women of 10-25 years of age at study start. (clinicaltrials.gov)
  • A woman between, and including, 10 and 25 years of age at the time of the first vaccination. (clinicaltrials.gov)
  • The vaccines provide protection for at least 5 to 10 years. (wikipedia.org)
  • They are recommended for women and men who are 9 to 45 years of age in the United States. (wikipedia.org)
  • Evidence for cross-protection but not type-replacement over the 11 years after human papillomavirus vaccine introduction. (nih.gov)
  • HPV vaccination is recommended for preteen girls and boys at age 11 or 12 years. (oncologynurseadvisor.com)
  • The rationale for changing screening recommendations to begin screening at 21 and to screen less frequently is based on strong evidence that some HPV-associated cervical abnormalities can resolve without medical intervention, especially in young women aged less than 21 years," Hariri said. (reuters.com)
  • 2 The intranasally administered live, attenuated influenza vaccine may be given only to healthy children aged 2 years and older and to healthy, nonpregnant adults younger than 50 years. (uspharmacist.com)
  • Asked of females and males between the ages of 18 to 49 years. (nc.us)
  • young
  • Background/introduction Australia introduced the national quadrivalent human papillomavirus (4vHPV) vaccination programme in April 2007 in young women and included young boys in Feb 2013. (bmj.com)
  • Using Mobile Technology to Improve Bone-Related Lifestyle Risk Factors in Young Women With Low Bone Mineral Density: Feasibility Randomized Controlled Trial. (jmir.org)
  • Any state or local government now beset by Merck's lobbying campaigns to mandate this HPV vaccine for young girls ought to take a look at these adverse health reports. (judicialwatch.org)